カテゴリー： Market Monitor Global, 世界, 医療/バイオ

勃起不全治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Erectile Dysfunction Treatment Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5547）◆商品コード：MMG23JU5547
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：66
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Erectile Dysfunction Treatment Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの勃起不全治療薬市場規模と予測を収録しています。・世界の勃起不全治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の勃起不全治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の勃起不全治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ホスホジエステラーゼ5型阻害剤」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

勃起不全治療薬のグローバル主要企業は、Pfizer Inc.、 Dong-A Pharmaceutical Co. Ltd、 Vivus, Inc.、 Meda Pharmaceuticals、 Bayer AG、 Johnson & Johnson Services、 Apricus Biosciences、 Eli Lillyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、勃起不全治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の勃起不全治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の勃起不全治療薬市場：タイプ別市場シェア、2022年
・ホスホジエステラーゼ5型阻害剤、プロスタグランジンE1

世界の勃起不全治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の勃起不全治療薬市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の勃起不全治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の勃起不全治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における勃起不全治療薬のグローバル売上、2018年-2023年
・主要企業における勃起不全治療薬のグローバル売上シェア、2022年
・主要企業における勃起不全治療薬のグローバル販売量、2018年-2023年
・主要企業における勃起不全治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer Inc.、 Dong-A Pharmaceutical Co. Ltd、 Vivus, Inc.、 Meda Pharmaceuticals、 Bayer AG、 Johnson & Johnson Services、 Apricus Biosciences、 Eli Lilly

*************************************************************

・調査・分析レポートの概要
勃起不全治療薬市場の定義
市場セグメント
世界の勃起不全治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の勃起不全治療薬市場規模
世界の勃起不全治療薬市場規模：2022年 VS 2029年
世界の勃起不全治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの勃起不全治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の勃起不全治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ホスホジエステラーゼ5型阻害剤、プロスタグランジンE1
勃起不全治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
勃起不全治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別勃起不全治療薬市場規模 2022年と2029年
地域別勃起不全治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer Inc.、 Dong-A Pharmaceutical Co. Ltd、 Vivus, Inc.、 Meda Pharmaceuticals、 Bayer AG、 Johnson & Johnson Services、 Apricus Biosciences、 Eli Lilly
...

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment Drugs. This report contains market size and forecasts of Erectile Dysfunction Treatment Drugs in global, including the following market information:
Global Erectile Dysfunction Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Erectile Dysfunction Treatment Drugs market was valued at US$ 4995.6 million in 2022 and is projected to reach US$ 6356.9 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erectile Dysfunction Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Phosphodiesterase Type 5 Inhibitors
Prostaglandin E1
Global Erectile Dysfunction Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinic
Others
Global Erectile Dysfunction Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Erectile Dysfunction Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Erectile Dysfunction Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Dong-A Pharmaceutical Co. Ltd
Vivus, Inc.
Meda Pharmaceuticals
Bayer AG
Johnson & Johnson Services
Apricus Biosciences
Eli Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Erectile Dysfunction Treatment Drugs, market overview.
Chapter 2: Global Erectile Dysfunction Treatment Drugs market size in revenue.
Chapter 3: Detailed analysis of Erectile Dysfunction Treatment Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Erectile Dysfunction Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Erectile Dysfunction Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Erectile Dysfunction Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Erectile Dysfunction Treatment Drugs Overall Market Size
2.1 Global Erectile Dysfunction Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Erectile Dysfunction Treatment Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Erectile Dysfunction Treatment Drugs Players in Global Market
3.2 Top Global Erectile Dysfunction Treatment Drugs Companies Ranked by Revenue
3.3 Global Erectile Dysfunction Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Erectile Dysfunction Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Erectile Dysfunction Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Erectile Dysfunction Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Erectile Dysfunction Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Phosphodiesterase Type 5 Inhibitors
4.1.3 Prostaglandin E1
4.2 By Type – Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
4.2.1 By Type – Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2023
4.2.2 By Type – Global Erectile Dysfunction Treatment Drugs Revenue, 2024-2029
4.2.3 By Type – Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Erectile Dysfunction Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
5.2.1 By Application – Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2023
5.2.2 By Application – Global Erectile Dysfunction Treatment Drugs Revenue, 2024-2029
5.2.3 By Application – Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Erectile Dysfunction Treatment Drugs Market Size, 2022 & 2029
6.2 By Region – Global Erectile Dysfunction Treatment Drugs Revenue & Forecasts
6.2.1 By Region – Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2023
6.2.2 By Region – Global Erectile Dysfunction Treatment Drugs Revenue, 2024-2029
6.2.3 By Region – Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.3.2 US Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.3.3 Canada Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.3.4 Mexico Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.4.2 Germany Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.3 France Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.4 U.K. Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.5 Italy Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.6 Russia Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.4.8 Benelux Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.5.2 China Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.3 Japan Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.4 South Korea Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.5.6 India Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.6.2 Brazil Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.6.3 Argentina Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue, 2018-2029
6.7.2 Turkey Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7.3 Israel Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
6.7.5 UAE Erectile Dysfunction Treatment Drugs Market Size, 2018-2029
7 Erectile Dysfunction Treatment Drugs Companies Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Major Product Offerings
7.1.4 Pfizer Inc. Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Dong-A Pharmaceutical Co. Ltd
7.2.1 Dong-A Pharmaceutical Co. Ltd Company Summary
7.2.2 Dong-A Pharmaceutical Co. Ltd Business Overview
7.2.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Major Product Offerings
7.2.4 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Dong-A Pharmaceutical Co. Ltd Key News & Latest Developments
7.3 Vivus, Inc.
7.3.1 Vivus, Inc. Company Summary
7.3.2 Vivus, Inc. Business Overview
7.3.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Major Product Offerings
7.3.4 Vivus, Inc. Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Vivus, Inc. Key News & Latest Developments
7.4 Meda Pharmaceuticals
7.4.1 Meda Pharmaceuticals Company Summary
7.4.2 Meda Pharmaceuticals Business Overview
7.4.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Major Product Offerings
7.4.4 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Meda Pharmaceuticals Key News & Latest Developments
7.5 Bayer AG
7.5.1 Bayer AG Company Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Erectile Dysfunction Treatment Drugs Major Product Offerings
7.5.4 Bayer AG Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 Bayer AG Key News & Latest Developments
7.6 Johnson & Johnson Services
7.6.1 Johnson & Johnson Services Company Summary
7.6.2 Johnson & Johnson Services Business Overview
7.6.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Major Product Offerings
7.6.4 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Services Key News & Latest Developments
7.7 Apricus Biosciences
7.7.1 Apricus Biosciences Company Summary
7.7.2 Apricus Biosciences Business Overview
7.7.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Major Product Offerings
7.7.4 Apricus Biosciences Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 Apricus Biosciences Key News & Latest Developments
7.8 Eli Lilly
7.8.1 Eli Lilly Company Summary
7.8.2 Eli Lilly Business Overview
7.8.3 Eli Lilly Erectile Dysfunction Treatment Drugs Major Product Offerings
7.8.4 Eli Lilly Erectile Dysfunction Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Erectile Dysfunction Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Erectile Dysfunction Treatment Drugs Market Drivers in Global Market
Table 3. Erectile Dysfunction Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Erectile Dysfunction Treatment Drugs in Global Market
Table 5. Top Erectile Dysfunction Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Erectile Dysfunction Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Erectile Dysfunction Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Erectile Dysfunction Treatment Drugs Product Type
Table 9. List of Global Tier 1 Erectile Dysfunction Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Erectile Dysfunction Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Erectile Dysfunction Treatment Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Erectile Dysfunction Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Erectile Dysfunction Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Inc. Company Summary
Table 31. Pfizer Inc. Erectile Dysfunction Treatment Drugs Product Offerings
Table 32. Pfizer Inc. Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Inc. Key News & Latest Developments
Table 34. Dong-A Pharmaceutical Co. Ltd Company Summary
Table 35. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Product Offerings
Table 36. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Dong-A Pharmaceutical Co. Ltd Key News & Latest Developments
Table 38. Vivus, Inc. Company Summary
Table 39. Vivus, Inc. Erectile Dysfunction Treatment Drugs Product Offerings
Table 40. Vivus, Inc. Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Vivus, Inc. Key News & Latest Developments
Table 42. Meda Pharmaceuticals Company Summary
Table 43. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Product Offerings
Table 44. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Meda Pharmaceuticals Key News & Latest Developments
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Erectile Dysfunction Treatment Drugs Product Offerings
Table 48. Bayer AG Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Johnson & Johnson Services Company Summary
Table 51. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Product Offerings
Table 52. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Services Key News & Latest Developments
Table 54. Apricus Biosciences Company Summary
Table 55. Apricus Biosciences Erectile Dysfunction Treatment Drugs Product Offerings
Table 56. Apricus Biosciences Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Apricus Biosciences Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Erectile Dysfunction Treatment Drugs Product Offerings
Table 60. Eli Lilly Erectile Dysfunction Treatment Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
List of Figures
Figure 1. Erectile Dysfunction Treatment Drugs Segment by Type in 2022
Figure 2. Erectile Dysfunction Treatment Drugs Segment by Application in 2022
Figure 3. Global Erectile Dysfunction Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Erectile Dysfunction Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Erectile Dysfunction Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Erectile Dysfunction Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 16. US Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 28. China Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Erectile Dysfunction Treatment Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Erectile Dysfunction Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Inc. Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Vivus, Inc. Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer AG Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Apricus Biosciences Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly Erectile Dysfunction Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 勃起不全治療薬の世界市場見通し2023年-2029年(Erectile Dysfunction Treatment Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の抗勃起不全（ED）治療薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の勃起不全デバイス市場2023-2030：種類別（真空収縮装置、陰茎インプラント、衝撃波療法、その他）、年齢層別（40歳以下、40～60歳、60歳以上）、原因別（血管障害＆糖尿病、神経障害、その他）、エンドユーザー別（病院、ASC、診療所）、地域別
  • 勃起不全衝撃波治療用装置のグローバル市場予測2023-2029

    • ◆H&Iグローバルリサーチのお客様（例）◆